Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-034060
Filing Date
2022-06-03
Accepted
2022-06-03 16:30:41
Documents
2
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1620
2 POA DOCUMENT poa.txt EX-24 3659
  Complete submission text file 0001209191-22-034060.txt   6699
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Issuer) CIK: 0001604477 (see all company filings)

EIN.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SQZ BIOTECHNOLOGIES COMPANY 200 ARSENAL YARDS BOULEVARD, SUITE 210 WATERTOWN MA 02472
Business Address
Warren Marshelle Smith (Reporting) CIK: 0001932203 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39662 | Film No.: 22994953